Oncolytic virotherapy is a field dedicated to exploiting viruses in the battle against cancer, where their specific cytolytic effects are sorely needed. This work focuses on the mechanisms and limitations of oncolytic virotherapy, on the recent advances in the field and on the potential oncolytic viruses hold for the future
New cancer therapies with novel mechanisms and functions are needed to treat patients with different...
According to the World Health Organization, cancer is the second leading cause of death in the world...
The approval of the first oncolytic virus (OV) for the treatment of metastatic melanoma and the rece...
Oncolytic virotherapy exploits live viruses with selective tropism for cancerous cells and tissues t...
Abstract Oncolytic viruses have found a good place in the treatment of cancer. Administering oncolyt...
Building on their success in vaccination, many groups are now exploring the use of viruses as antica...
The American Cancer Society estimates that in 2023, 1,958,310 new cancer cases and 609,820 cancer de...
Oncolytic virotherapy is a therapeutic approach that uses replication-competent viruses to kill canc...
Despite great medical advances, oncological research is still looking for novel therapeutic approach...
Cancer remains a leading cause of death worldwide. Despite many signs of progress, currently availab...
Current oncolytic virotherapy strategies are based in the accumulated understanding of the common mo...
The current regimen of cancer therapy (chemotherapy and radiotherapy) suffers with disadvantages suc...
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therap...
Oncolytic viruses are multifunctional anticancer agents with huge clinical potential, and have recen...
The past decade has seen considerable excitement in the use of biological therapies in treating neop...
New cancer therapies with novel mechanisms and functions are needed to treat patients with different...
According to the World Health Organization, cancer is the second leading cause of death in the world...
The approval of the first oncolytic virus (OV) for the treatment of metastatic melanoma and the rece...
Oncolytic virotherapy exploits live viruses with selective tropism for cancerous cells and tissues t...
Abstract Oncolytic viruses have found a good place in the treatment of cancer. Administering oncolyt...
Building on their success in vaccination, many groups are now exploring the use of viruses as antica...
The American Cancer Society estimates that in 2023, 1,958,310 new cancer cases and 609,820 cancer de...
Oncolytic virotherapy is a therapeutic approach that uses replication-competent viruses to kill canc...
Despite great medical advances, oncological research is still looking for novel therapeutic approach...
Cancer remains a leading cause of death worldwide. Despite many signs of progress, currently availab...
Current oncolytic virotherapy strategies are based in the accumulated understanding of the common mo...
The current regimen of cancer therapy (chemotherapy and radiotherapy) suffers with disadvantages suc...
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therap...
Oncolytic viruses are multifunctional anticancer agents with huge clinical potential, and have recen...
The past decade has seen considerable excitement in the use of biological therapies in treating neop...
New cancer therapies with novel mechanisms and functions are needed to treat patients with different...
According to the World Health Organization, cancer is the second leading cause of death in the world...
The approval of the first oncolytic virus (OV) for the treatment of metastatic melanoma and the rece...